This event has passed.

ACI presents FDA Boot Camp: Hatch-Waxman and BPCIA in the Trenches: Exclusivity and Bioequivalency Working Group

March 24, 2022 @ 2:00 PM - 5:30 PM ET


This workshop will build upon the content covered during the FDA Boot Camp main conference on the regulatory and IP interplay in the Hatch-Waxman and BPCIA schematics. Wolf Greenfield's Jon Roses will lead the workshop with Brian Malkin of McDermott Will & Emery LLP in a step by-step manner to:

  • Deconstruct complex exclusivity disputes
  • Analyze FDA 's and the disputing parties ' various (and sometimes evolving) positions on exclusivity
  • Explore bioequivalency conundrums

Relevant court decisions will also be analyzed and their practical and future effects discussed. Read more.

To receive 10% off registration, use code: S10-874-874L22.S


March 24, 2022
2:00 PM - 5:30 PM ET